AddLife AB Share Price
Stocks
ALIF B
SE0014401378
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Delayed
Nasdaq Stockholm
09:30:00 15/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 175.90 SEK | +0.51% |
|
+5.27% | +10.56% |
| 13/10 | Stockholm Stock Exchange ended Tuesday with a slight gain | FW |
| 13/10 | Stockholm stock market opens higher with AstraZeneca leading the way, OMXS30 index up 0.5 percent | FW |
| Market Cap | 2.13TCr 214.01Cr 191.02Cr 177.54Cr 161.49Cr 303.83Cr 20TCr 309.3Cr 834.41Cr 11TCr 803.1Cr 786.09Cr 34TCr | P/E 2026 * |
39.8x | P/E 2027 * | 31x |
|---|---|---|---|---|---|
| Enterprise Value | 2.54TCr 254.44Cr 227.11Cr 211.08Cr 192Cr 361.23Cr 24TCr 367.74Cr 992.05Cr 13TCr 954.83Cr 934.6Cr 40TCr | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 2.1x |
| Free-Float |
90.68% | Yield 2026 * |
0.96% | Yield 2027 * | 1.2% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ALIF B | Delayed | |
CBOE
| ALIFBs | Real-time | |
London S.E.
| 0REZ | Delayed | |
CBOE
| 0REZ | Real-time | |
Deutsche Boerse AG
| 1AD1 | Delayed | |
Boerse Muenchen
| 1AD1 | Real-time | |
Börse Stuttgart
| 1AD1 | Delayed |
Last Transcript: AddLife AB
| 1 day | +0.77% | ||
| 1 week | +5.27% | ||
| Current month | +2.27% | ||
| 1 month | +10.21% | ||
| 3 months | +6.03% | ||
| 6 months | +10.21% | ||
| Current year | +10.56% |
| 1 week | 167.2 | 176.9 | |
| 1 month | 156.6 | 177.7 | |
| Current year | 130.2 | 177.7 | |
| 1 year | 130.2 | 208.4 | |
| 3 years | 54.75 | 208.4 | |
| 5 years | 54.75 | 395 | |
| 10 years | 32.25 | 395 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fredrik Dalborg
CEO | Chief Executive Officer | 54 | 01/01/2022 |
| Director of Finance/CFO | 56 | 01/01/2022 | |
| Chief Tech/Sci/R&D Officer | 57 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Johan Olov Sjö
CHM | Chairman | 59 | 05/03/2015 |
Stefan Hedelius
BRD | Director/Board Member | 57 | 01/01/2015 |
Eva Nilsagård
BRD | Director/Board Member | 62 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/08/26 | Buy | Chief Executive Officer | 500 | 0.0004% | ||
| 27/08/26 | Buy | Chief Executive Officer | 30 | 0.0000% | ||
| 26/08/26 | Buy | Chief Executive Officer | 24 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.51% | +5.27% | -1.79% | +189.31% | 211.79Cr | ||
| +2.47% | +6.13% | -19.25% | +13.39% | 18TCr | ||
| +1.41% | +8.46% | -0.18% | +32.64% | 12TCr | ||
| +3.27% | +4.67% | -21.60% | +9.77% | 11TCr | ||
| +0.41% | +3.99% | -44.97% | -10.22% | 7.57TCr | ||
| +1.76% | +6.19% | +6.77% | +82.62% | 6.42TCr | ||
| -1.75% | -0.72% | +17.66% | +59.66% | 5.35TCr | ||
| +2.06% | +5.31% | +3.04% | -25.91% | 5.15TCr | ||
| +2.81% | +5.72% | -15.12% | +26.29% | 4.17TCr | ||
| +3.36% | +2.24% | +31.94% | +9.31% | 3.15TCr | ||
| Average | +1.65% | +3.40% | -4.35% | +38.69% | 7.27TCr | |
| Weighted average by Cap. | +1.85% | +4.20% | -10.02% | +21.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.1TCr 110.21Cr 98Cr 91Cr 83Cr 156.47Cr 10TCr 159.29Cr 429.71Cr 5.45TCr 413.59Cr 404.83Cr 17TCr | 1.19TCr 118.96Cr 106.18Cr 99Cr 90Cr 168.89Cr 11TCr 171.93Cr 463.83Cr 5.88TCr 446.43Cr 436.97Cr 19TCr |
| Net income | 54Cr 5.38Cr 4.8Cr 4.46Cr 4.06Cr 7.63Cr 509.23Cr 7.77Cr 21Cr 265.69Cr 20Cr 20Cr 850.19Cr | 69Cr 6.89Cr 6.15Cr 5.71Cr 5.2Cr 9.78Cr 652.37Cr 9.95Cr 27Cr 340.37Cr 26Cr 25Cr 1.09TCr |
| Net Debt | 402.9Cr 40Cr 36Cr 34Cr 31Cr 57Cr 3.83TCr 58Cr 157.64Cr 2TCr 151.72Cr 148.51Cr 6.39TCr | 353.95Cr 36Cr 32Cr 29Cr 27Cr 50Cr 3.36TCr 51Cr 138.49Cr 1.76TCr 133.29Cr 130.47Cr 5.62TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | SEK 175.90 | +0.51% | 1,27,949 |
| 14/26/14 | SEK 175.00 | +1.16% | 1,02,122 |
| 13/26/13 | SEK 173.00 | +2.37% | 47,758 |
| 12/26/12 | SEK 169.00 | 0.00% | 74,739 |
| 09/26/09 | SEK 169.00 | +1.14% | 67,582 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALIF B Stock
Select your edition
All financial news and data tailored to specific country editions

















